drugset / Trial / NCT02134093
Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients
RandomizedParallel-groupDouble-blindPrevention
Summary
This study is to explore the effects of dexmedetomidine on postoperative cognitive dysfunction during one-lung ventilation in elder patients.
Timeline
- Start
- 2014-07
- Primary completion
- 2015-05
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.2 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 0.4 ug/kg | — |
| Background | Etomidate | Small molecule | 0.2 mg/kg | — |
| Background | Etomidate | Small molecule | 0.6 mg/kg | — |
| Background | Midazolam | Small molecule | 0.03 mg/kg | — |
| Background | Midazolam | Small molecule | 0.05 mg/kg | — |
| Background | Propofol | Small molecule | 3 mg/kg | — |
| Background | Propofol | Small molecule | 6 mg/kg | — |
| Background | Remifentanil | Small molecule | 0.05 ug/kg | — |
| Background | Remifentanil | Small molecule | 0.3 ug/kg | — |
| Background | Rocuronium | Other / unclassified | 0.6 mg/kg | — |
| Background | Sufentanil | Other / unclassified | 0.5 ug/kg | — |
| Background | Sufentanil | Other / unclassified | 0.8 ug/kg | — |
| Background | Vecuronium | Small molecule | 0.05 mg/kg | — |
| Background | Vecuronium | Small molecule | 0.1 mg/kg | — |
Indications
No indication recorded.